The study covers geographic analysis that includes Countries like India, China, Australia and New Zealand, Rest of Asia-Pacific and important players/vendors such as Wockhardt, Roche Holding, Abbott Laboratories, i-SENS, Terumo Medical etc.The report will help you gain market insights, future trends and growth prospects for forecast period of 2019-2025.
The Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the 2019-2024 period, owing to technological breakthroughs, rising obesity, and the increasing prevalence of diabetes.
Product Segment Insights:
The testing strips segment is expected to hold the highest market share (81.64%) in 2019. Owing to the development of innovative testing strips, and a massive increase in the incidence of diabetes, this segment is expected to witness a high CAGR of 6.94% during the forecast period. The glucometers segment is expected to remain steady while generating 12% of the revenue in the Asia-Pacific market in 2019. Factors like the advantages of glucometers over regular monitoring methodologies and the production of a wide range of devices will drive this segment. However, variations in results due to external and physiological factors will lead to a comparatively low CAGR (4.95%) during the 2019-2024 period.
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=2210059
End User Segment Insights:
The shift of medical services to decentralized surroundings like patients’ homes and the development of portable and user-friendly blood glucose monitoring devices will enable the home settings segment to expand at a CAGR of 6.82% during the 2019-2024 period. The hospitals sector will generate almost 7% of the total market revenue by 2019, and is anticipated to expand at a CAGR of 4.78% during the forecast period.
China and India account for half of the total diabetic population in the Asia-Pacific region. Advanced medical facilities, awareness programs, and cost-effective treatments to tackle diabetes will transform this region into the fastest-growing SMBG devices market in the world. China is expected to expand at a CAGR of 6.62% during the forecast period, while healthcare initiatives and government programs in India will enable the market in the country to expand at a CAGR of 6.46%.
• Roche Holding
• Abbott Laboratories
• Terumo Medical
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/2210059-asia-pacific-self-monitoring-blood-glucose-devices-market
Chapter 1. Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive summary
Chapter 2: Asia-Pacific self-monitoring blood glucose devices market – overview
2.1. Market definitions
2.2. Market overview
– Historical market revenue (USD Bn)
– Forecasted market revenue (USD Bn)
– Country-wise market revenue (USD Bn)
2.3. Market trends
2.4. Market drivers
2.5. Market challenges
2.6. Value chain analysis
2.7. Porter’s five forces analysis
Chapter 3: Asia-Pacific self-monitoring blood glucose devices market – based on products
3.1. Testing strips
– Market overview
– Forecasted market segment reven
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2210059-asia-pacific-self-monitoring-blood-glucose-devices-market
It’s vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.
Company Name: HTF Market Intelligence Consulting Private Limited
Contact Person: Craig Francis
Email: Send Email
Address:Unit No. 429, Parsonage Road
State: New Jersey
Country: United States